Review Article
Laparoscopic Surgery for Recurrent Crohn's Disease
Table 2
Significant short-term (30 days) outcomes.
| | | | | | | | | Days to | Authors | Operative time (min) | Loss bood (mL) | Morbidity | Reintervention | Readmission | Mortality | Length of stay (days) | soft diet | flatus | stools |
| Wu et al. | 144 versus 202* | 131 versus 245* | 10% versus 21% | 0 versus 4% | 0 versus 4% | 0 versus 1% | 3.9 versus 7.9* | 3-4 | 2-3 | 3-4 | Hasegawa et al. | 180 versus 210 | 50 versus 80 | 13% versus 19% | NR | NR | 0 | 8 versus 8 | NR | NR | NR | Uchikoshi et al. | 204 versus 232 | 548 versus 361* | 25%** versus 18%** | NR | NR | 0 | 42.5 versus 22.4* | 32 versus 14* | 3.6 versus 2.6* | NR | Hoorthy et al. | 127 versus 118 | 350 versus 273 | 13.5% versus 15.4% | NR | NR | 0 | 7 versus 8 | 4 versus 5 | NR | NR | Lawes and Motson | 100 | NR | 7% | NR | NR | 0 | 5 | NR | NR | NR | Goyer et al. | 214 versus 191* | NR | 17% versus 17% | 0 versus 2% | NR | 0 | 8 versus 7 | NR | NR | NR | Broquet et al. | 226 versus 215 | NR | 30% versus 38% | 6% versus 7% | NR | 0 | 9 versus 9 | NR | NR | NR | Chaudhray et al. | 85 versus 125* | NR | 24% versus 17% | 7% versus 3% | 7% versus 3% | 0 | 3 versus 3 | NR | NR | NR | Holubar et al. | 159 versus 165 | 100 versus 150 | 10% versus 30% | 0% versus 10% | 3% versus 10% | 0 | 4 versus 7* | 3 versus 4 | 3 versus 4 | 4 versus 4 | Pinto et al. | 182 versus 201 | 161 versus 201 | 36% versus 40% | 10% versus 6% | NR | 0 | 6.7 versus 7.4 | 4 versus 4 | NR | 4.6 versus 4.3 | Bandyopadhyay et al. | 110 (70–170) | 50 (25–250) | 7.4% | NR | 0 | 0 | 4 (2–7) | 1 | NR | 2 (1–3) |
|
|
*
value < 0.05.
**Wound infection. NR: not reported days.
|